HIV and AIDS Trial, Recruiting NCT06684613 Sponsor: Yale University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06684613
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 years or older
  • People who have a uterus
  • People who do not have HIV (based on self-reporting)
  • People who are not currently taking PrEP (a medication used to prevent HIV)
  • People who are comfortable having conversations in English or Spanish
  • People who are able to take part in the informed consent process (understanding and agreeing to the study details)
  • Sexual and reproductive health clinicians who provide patient care at one of the participating clinic sites
  • Clinic staff who work at one of the participating sites, whether or not their role involves direct patient contact

Who may not be able to join:

  • People who are not able to become pregnant — for example, those who have had a hysterectomy (removal of the uterus) or tubal ligation (tubes tied)
  • People who are hoping to become pregnant, as they would not qualify for the pregnancy prevention counselling part of the study
  • People who already have a scheduled appointment with a member of the research team (this is to reduce the chance of study results being affected by prior contact)
  • People who have already taken part in Aim 1 of this study are not eligible to also participate in Aim 2

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jaimie P Meyer, MD, Yale Clinical and Community Research, Yale School of Medicine

Phone: 2034998075

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
11 March 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PrEP initiation (prescribing); Feasibility of implementing the enhanced PrEP decision aid in SRH settings, according to the Proctor taxonomy; Acceptability of the enhanced PrEP decision aid within SRH settings, according to users (Proctor taxonomy); Penetration (reach) of the enhanced decision aid within SRH clinics (Proctor taxonomy); Penetration (reach) of the enhanced decision aid within SRH clinics (Proctor taxonomy); Penetration (reach) of the enhanced decision aid within SRH clinics (Proctor taxonomy); Adoption of the enhanced PrEP decision aid within SRH settings, according to users (Pr...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov